Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01WAI
|
|||
Former ID |
DNC003810
|
|||
Drug Name |
DEBROMOHYMENIALDISINE
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C11H11N5O2
|
|||
Canonical SMILES |
C1CNC(=O)C2=C(C1=C3C(=O)NC(=N3)N)C=CN2
|
|||
InChI |
1S/C11H11N5O2/c12-11-15-8(10(18)16-11)6-2-4-14-9(17)7-5(6)1-3-13-7/h1,3,13H,2,4H2,(H,14,17)(H3,12,15,16,18)/b8-6-
|
|||
InChIKey |
JYRJOQGKGMHTOO-VURMDHGXSA-N
|
|||
CAS Number |
CAS 125118-55-0
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Potent inhibition of checkpoint kinase activity by a hymenialdisine-derived indoloazepine. Bioorg Med Chem Lett. 2004 Aug 16;14(16):4319-21. | |||
REF 2 | Aldisine alkaloids from the Philippine sponge Stylissa massa are potent inhibitors of mitogen-activated protein kinase kinase-1 (MEK-1). J Med Chem. 2002 Jan 17;45(2):529-32. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.